ResearcherJohns Hopkins UniversityNo recent work listed
Anne Le
Matched on ORCID iD 0000-0002-2958-8149; OpenAlex author ID A5034847293; NIH RePORTER profile ID 10804314. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 0
- Grants
- 2
- Labs led
- 1
- Collaborators
- 16
2012: 1 paper · 2013: none · 2014: 1 grant · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 grant
Papers 4
- Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer. Last author DOI 10.1002/pmic.201800451↗
- Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer. Last author DOI 10.1073/pnas.1611406113↗
- Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function. Co-author DOI 10.1158/0008-5472.can-15-0108↗
- Conceptual framework for cutting the pancreatic cancer fuel supply. Co-author DOI 10.1158/1078-0432.ccr-12-0041↗
Grants 2
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Justin S. Hanes · 2 shared papers, 1 shared grant, 2016–2020 · strength 0.49
- Grant Glutaminase Inhibitor Drug Discovery and Nanoparticle-Based Delivery for Pancreatic Cancer Therapy R01CA193895↗
- Paper Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancrea… DOI 10.1002/pmic.201800451↗
- Paper Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer. DOI 10.1073/pnas.1611406113↗
- Barbara Stauch Slusher · 2 shared papers, 1 shared grant, 2016–2020 · strength 0.49
- Grant Glutaminase Inhibitor Drug Discovery and Nanoparticle-Based Delivery for Pancreatic Cancer Therapy R01CA193895↗
- Paper Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancrea… DOI 10.1002/pmic.201800451↗
- Paper Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer. DOI 10.1073/pnas.1611406113↗
- Amira Elgogary · 2 shared papers, 2016–2019 · strength 0.12
- Paper Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancrea… DOI 10.1002/pmic.201800451↗
- Paper Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer. DOI 10.1073/pnas.1611406113↗
- Jie Fu · 2 shared papers, 2016–2019 · strength 0.12
- Paper Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancrea… DOI 10.1002/pmic.201800451↗
- Paper Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer. DOI 10.1073/pnas.1611406113↗
- N.V. Rajeshkumar · 2 shared papers, 2012–2015 · strength 0.09
- Anirban Maitra · 2 shared papers, 2012–2015 · strength 0.09
- Chi Van Dang · 2 shared papers, 2012–2015 · strength 0.09
- Sunag Udupa · 1 shared paper, 2019 · strength 0.07
- Robert J. Gillies · 1 shared paper, 2015 · strength 0.04
- Shinichi Yabuuchi · 1 shared paper, 2015 · strength 0.04
- Jurre J. Kamphorst · 1 shared paper, 2015 · strength 0.04
- Prasanta Dutta · 1 shared paper, 2015 · strength 0.04
- Roeland F. de Wilde · 1 shared paper, 2015 · strength 0.04
- Manuel M. Hidalgo · 1 shared paper, 2015 · strength 0.04
- Joshua D. Rabinowitz · 1 shared paper, 2015 · strength 0.04
- Sarah Zimmermann · 1 shared paper, 2016 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.